"Providence Saint John’s is a nationally renowned 266-bed hospital with physicians, nurses, volunteers and support staff who work as a team to provide the best possible medical care to its patients and the community. Providence Saint John’s provides the latest in diagnostic technology and specialty care with a strong commitment to its core service lines: heart and vascular care, oncology, orthopedics and women’s health. Saint John’s also is home to the world-renowned Cancer Institute, dedicated to clinical research and medical advancements in cancer care."

During the past decade, Providence Saint John's Health Center conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 9 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 9 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Saint John's Health Center" #1 sponsor was "UroGen Pharma Ltd." with 4 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "EpicentRx, Inc." with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Saint John's Health Center" #1 collaborator was "Boston Medical Center" with 2 trials as a collaborator, "First Choice Community Healthcare" with 2 trials as a collaborator, "Hidalgo Medical Services" with 2 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator and "Olive View-UCLA Education & Research Institute" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Providence Saint John's Health Center" are "Bladder Cancer" (5 trials), "Melanoma" (3 trials), "Urothelial Carcinoma" (3 trials), "Urothelial Carcinoma Bladder" (3 trials) and "Addiction" (2 trials). Many other conditions were trialed in "Providence Saint John's Health Center" in a lesser frequency.

Most popular intervention types in "Providence Saint John's Health Center" are "Drug" (26 trials), "Biological" (8 trials), "Device" (7 trials), "Behavioral" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Remdesivir" (3 trials), "UGN-102" (3 trials), "Pegloticase" (2 trials), "Placebo" (2 trials) and "Standard of Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Providence Saint John's Health Center" are 37 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Saint John's Health Center". undefined are not yet recruiting, 14 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Providence Saint John's Health Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Saint John's Health Center, 8 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

Providence Saint John's Health Center has several departments that took part in Clinical trials: "John Wayne Cancer Institute at Providence Saint John's Health Center" - 23 trials